PTH and chronic kidney disease: This trend was evident in patients at stage 3 (incidence rate/100,000: 51.35 in CKD + sHPT and 10.32 in CKD patients) (Figure 3B), suggesting a possible link between the time of exposure to high PTH and clinical outcomes.